Digital Pathology Market by Product (Software, Storage & Communication Systems,and Scanners), Application (Disease Diagnosis, Training & Education, Teleconsultation, and Drug Discovery), End-User (Clinical, Educational,and Pharma & Biotech Companies) – Global Analysis & Forecast, 2020 – 2027

    14-January-2021 | 239 Pages | | Report Code : RC-263

The Global Digital Pathology Marketis expected to grow steadily at a CAGR of 13.4% from 2020 to 2027.Digital pathology is an image-based information setting for the management of information generated through a digital slide. The increased investment in laboratory expansion and market penetration of key manufacturers are expected to fuel the market growth in the coming four to five years. The use of digital pathology in disease diagnosis is also increasing, due to the integration of digital pathology with digital tools, specimen tracking, and barcoding which improves the efficiency and safety of disease diagnoses.


The growth in adoption of digital pathology as compared to conventional pathology diagnosis, and the rising prevalence of chronic conditions coupled with a surge in demand for faster diagnostic tools for chronic diseases, such as cancer, are amongst the major factors supplementing the market growth. The market is also boosted by the rising healthcare expenditure in the developed countries, increasing adoption of telepathology, and an increasing focus on drug discovery. The market penetration of key manufacturers in the developed region is fueling the demand in countries such as the U.S. and Canada.However, the dearth of skilled personneland the unwillingness of older pathologists to implement new technology is limiting the digital pathology market growth.


The global digital pathology market is segmented by product, application, and end-user. By product,the market is divided into software,scanners, and storage & communication systems. By application, the market is segmented into teleconsultation, drug discovery, disease diagnosis, and training & education. On the basis of end-user, the market is split into clinical, educational, and pharma & biotech companies.North America, Europe, Asia-Pacific, andLAMEA are the geographical breakdowns of the digital pathology market at the global level. Moreover, the country-wise market analysis has been also covered under the scope of the report.


The scanners segment is the prominent market and is expected to register a significant growth rate during the forecast period as these systems perform repeated data analysis across experiments and produce high-resolution images.Pharma & biotech companies dominated the end-user segment accounting for the major share of the market revenue. The leading market players includeHamamatsu Photonics K.K., Danaher Corporation, Glencoe Software, Inc., 3DHISTECH Ltd.,Indica Labs Inc., PerkinElmer Inc., Roche (Ventana Medical Systems, Inc.), Koninklijke Philips N.V., Nikon Corporation,and Visiopharm A/S, among others.


Digital Pathology Market Key Segments:


Product Segments
   Storage & Communication Systems


Application Segments
   Disease Diagnosis
   Drug Discovery
   Training & Education


End-User Segments
   Pharma & Biotech Companies


Geographical Segments

•  North America
   o  The U.S.
   o  Canada
   o  Mexico

•  Europe
   o  UK
   o  Germany
   o  France
   o  Italy
   o  Spain
   o  Rest of Europe

•  Asia-Pacific
   o  India
   o  China
   o  Japan
   o  Australia
   o  South Korea
   o  Rest of Asia-Pacific

   o  Latin America
   o  The Middle East
   o  Africa



Ask For Customization of Report

Request For Report Sample

Ask For Discount


Abstract Market Research

Call at: +1-209-813-4101 | +91-9730047721

Send us an Email